Status:
UNKNOWN
The Combination Therapy of Nanofat Grafting and PRP Compared With Microfat Grafting and PRP Synergy in Treating Striae Distensae
Lead Sponsor:
First Affiliated Hospital of Jinan University
Collaborating Sponsors:
Science and Technology Program of Guangzhou,Guangzhou Sipintang Biological technology Co., Ltd.
Conditions:
Treatments of Striae Distensae
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
Striae distensae is caused by the fracture and damage of the elastic fibers and collagen fibers, which is still a difficulty to overcome. Based on the studies demonstrated that platelet-rich plasma(PR...
Detailed Description
The participants were randomly assigned into two groups. Group A is treated by nanofat grafting once every three months for 2 times combined with PRP injection once a month for 6 times. Group B will b...
Eligibility Criteria
Inclusion
- The striae distensae
- Age ≤ 35 years old
Exclusion
- Skin allergy
- Cicatricial diathesis
- Skin inflammation or wound
- Platelet dysfunction syndrome
- Take anticoagulant drugs
- Acute or chronic infection
- Chronic liver disease
- Active vitiligo, psoriasis, systemic lupus erythematosus
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03807986
Start Date
February 1 2019
End Date
December 31 2020
Last Update
January 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Jinan University
Guangzhou, Guangdong, China, 500011